Sumner M J, Humphrey P P
Pharmacology Division, Glaxo Group Research Ltd., Ware, Hertfordshire.
Br J Pharmacol. 1990 Feb;99(2):219-20. doi: 10.1111/j.1476-5381.1990.tb14682.x.
Sumatriptan (GR43175) contracts rings of dog isolated saphenous vein by an action at 5-HT1-like receptors. We have now examined the effects of sumatriptan on prostaglandin E2(PGE2)-stimulated adenosine 3':5'-cyclic monophosphate (cyclic AMP) accumulation in this tissue. Sumatriptan and 5-hydroxytryptamine (5-HT) produced a concentration-dependent inhibition of PGE2-stimulated cyclic AMP accumulation (EC50 values of 250 nM and 80 nM respectively), responses that were mimicked by 5-carboxamidotryptamine but not by U-46619 or methoxamine. The response to sumatriptan (1 microM) was antagonised by methiothepin (1 microM), but not by metergoline (0.1 microM), spiperone (1 microM) or ondansetron (GR38032, 1 microM). These results suggest that 5-HT1-like receptors which mediate contraction of the dog isolated saphenous vein are negatively coupled to adenylate cyclase in this preparation.
舒马曲坦(GR43175)通过作用于5-羟色胺1样受体使犬离体隐静脉环收缩。我们现在研究了舒马曲坦对该组织中前列腺素E2(PGE2)刺激的腺苷3':5'-环磷酸(环磷酸腺苷)积累的影响。舒马曲坦和5-羟色胺(5-HT)对PGE2刺激的环磷酸腺苷积累产生浓度依赖性抑制(EC50值分别为250 nM和80 nM),5-羧酰胺色胺可模拟该反应,但U-46619或甲氧明不能模拟。舒马曲坦(1 μM)的反应被甲硫噻平(1 μM)拮抗,但不被麦角苄酯(0.1 μM)、螺哌隆(1 μM)或昂丹司琼(GR38032,1 μM)拮抗。这些结果表明,介导犬离体隐静脉收缩的5-羟色胺1样受体在此制剂中与腺苷酸环化酶负偶联。